Loxapine launch PR on May 4th, 2021. Not a grand slam product but an additional launch since Adderall nonetheless.
Relatively small pharmaceutical company we’re talking about here and, notably, a pandemic has been in effect during those 3 years which has delayed clinical trials for some pipeline candidates.